Terms: = Head and neck cancer AND STAT5B, STAT5, 6777, ENSG00000173757, P51692 AND Prognosis
12 results:
1. Prognostic DNA mutation and mRNA expression analysis of perineural invasion in oral squamous cell carcinoma.
Kuk SK; Kim K; Lee JI; Pang K
Sci Rep; 2024 Jan; 14(1):2427. PubMed ID: 38287071
[TBL] [Abstract] [Full Text] [Related]
2. Porphyromonas gingivalis Activation of Tumor-Associated Macrophages via DOK3 Promotes Recurrence of Oral Squamous Cell Carcinoma.
Li CX; Su Y; Gong ZC; Liu H
Med Sci Monit; 2022 Oct; 28():e937126. PubMed ID: 36210538
[TBL] [Abstract] [Full Text] [Related]
3. The Functionalities and Clinical Significance of Tumor-Infiltrating Immune Cells in Esophageal Squamous Cell Carcinoma.
Zhang J; Wang H; Wu H; Qiang G
Biomed Res Int; 2021; 2021():8635381. PubMed ID: 34616847
[TBL] [Abstract] [Full Text] [Related]
4. Development and validation of a novel survival model for head and neck squamous cell carcinoma based on autophagy-related genes.
Ren Z; Zhang L; Ding W; Luo Y; Shi Z; Shrestha B; Kan X; Zhang Z; Ding J; He H; Hu X
Genomics; 2021 Jan; 113(1 Pt 2):1166-1175. PubMed ID: 33227411
[TBL] [Abstract] [Full Text] [Related]
5. Using The cancer Genome Atlas data to refine the 8th edition of the American Joint Committee on cancer staging for papillary thyroid carcinoma.
Poma AM; Macerola E; Torregrossa L; Elisei R; Santini F; Basolo F
Endocrine; 2021 Apr; 72(1):140-146. PubMed ID: 32915437
[TBL] [Abstract] [Full Text] [Related]
6. LncRNA WDFY3-AS2 suppresses proliferation and invasion in oesophageal squamous cell carcinoma by regulating miR-2355-5p/SOCS2 axis.
Zhang Q; Guan F; Fan T; Li S; Ma S; Zhang Y; Guo W; Liu H
J Cell Mol Med; 2020 Jul; 24(14):8206-8220. PubMed ID: 32536038
[TBL] [Abstract] [Full Text] [Related]
7. PRRX1-induced epithelial-to-mesenchymal transition in salivary adenoid cystic carcinoma activates the metabolic reprogramming of free fatty acids to promote invasion and metastasis.
Jiang YP; Tang YL; Wang SS; Wu JS; Zhang M; Pang X; Wu JB; Chen Y; Tang YJ; Liang XH
Cell Prolif; 2020 Jan; 53(1):e12705. PubMed ID: 31657086
[TBL] [Abstract] [Full Text] [Related]
8. Clinical features and the molecular biomarkers of olfactory neuroblastoma.
Peng X; Liu Y; Peng X; Wang Z; Zhang Z; Qiu Y; Jin M; Wang R; Kong D
Pathol Res Pract; 2018 Aug; 214(8):1123-1129. PubMed ID: 29921494
[TBL] [Abstract] [Full Text] [Related]
9. Prognostic significance of the EGFR pathway in nasopharyngeal carcinoma: a systematic review and meta-analysis.
Ooft ML; Braunius WW; Heus P; Stegeman I; van Diest PJ; Grolman W; Zuur CI; Willems SM
Biomark Med; 2015; 9(10):997-1010. PubMed ID: 26441207
[TBL] [Abstract] [Full Text] [Related]
10. Tumor-derived exosomes promote tumor progression and T-cell dysfunction through the regulation of enriched exosomal microRNAs in human nasopharyngeal carcinoma.
Ye SB; Li ZL; Luo DH; Huang BJ; Chen YS; Zhang XS; Cui J; Zeng YX; Li J
Oncotarget; 2014 Jul; 5(14):5439-52. PubMed ID: 24978137
[TBL] [Abstract] [Full Text] [Related]
11. Targeting the STAT pathway in head and neck cancer: recent advances and future prospects.
Nikitakis NG; Siavash H; Sauk JJ
Curr Cancer Drug Targets; 2004 Dec; 4(8):637-51. PubMed ID: 15578920
[TBL] [Abstract] [Full Text] [Related]
12. Constitutive activation of STAT3 and stat5 is present in the majority of nasopharyngeal carcinoma and correlates with better prognosis.
Hsiao JR; Jin YT; Tsai ST; Shiau AL; Wu CL; Su WC
Br J Cancer; 2003 Jul; 89(2):344-9. PubMed ID: 12865928
[TBL] [Abstract] [Full Text] [Related]
